01181nas a2200241   4500000000100000008004100001260001300042653001200055653002300067653001100090653001000101653001200111653001700123100001600140700001600156700001500172245012100187856004100308300001000349490000700359520055900366022001400925       1983                            d  c1983 Sep10aDapsone10aHome Care Services10aHumans10aIndia10aleprosy10aTime Factors1 aAlmeida J G1 aChristian M1 aChacko C J00aResults of long-term domiciliary dapsone (DDS) monotherapy for lepromatous leprosy in Gudiyatham Taluk, South India.  uhttp://ila.ilsl.br/pdfs/v51n3a14.pdf  a385-60 v513 a<p>At the Schieffelin Leprosy Research and Training Centre, Karigiri, India, data were assembled on all 58 living patients with lepromatous leprosy residing in Gudiyatham Taluk who had been registered in 1960 or earlier. They had received domiciliary oral DDS monotherapy for greater than 20 years. Fifty-one of the 58 patients were currently smear negative and clinically inactive. Patients with a Bacterial Index that had at some time been greater than or equal to 2+ were currently found smear positive more frequently than the remaining patients.</p>  a0148-916X